Company news

Genetic Signatures Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Addendum to Notice of Annual General Meeting

October 23, 2026

Update on Commercial Terms for the Proposed Merger with MAP

October 20, 2026

Update on Commercial Terms for Proposed Merger with MAP

October 20, 2026

Response to Media Speculation & BCAL letter to GSS

October 16, 2026

GSS: Response to Media Speculation & BCAL letter to GSS

October 16, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

October 7, 2026

GSS Investor Presentation - Proposed Merger with MAP

September 21, 2026

Receipt of Section 249D Notice from BCAL Diagnostics

September 16, 2026

BDX Holdings of GSS Shares and receipt of Section 249D

September 2, 2026

Genetic Signatures and Microba in Merger Discussions

August 25, 2026

FY26 Market Update

August 24, 2026

GSS responds to the BCAL Diagnostics Announcement

July 2, 2026

BCAL to Acquire Shares in Genetic Signatures

July 1, 2026

Danish Supply Agreement - Additional Information

April 15, 2026

Genetic Signatures Signs Danish Supply Agreement

April 14, 2026

Genetic Signatures Organisational Restructure

March 29, 2026

1H FY26 Results Release

February 25, 2026

1H FY26 Results Presentation

February 25, 2026

1H FY26 Appendix 4D and Half Year Report

February 25, 2026

GSS Appoints Anne Lockwood as Interim Managing Director

February 5, 2026

Genetic Signatures Appoints Maria Halasz as CEO

February 1, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 19, 2026

Leadership Change at Genetic Signatures Limited

December 14, 2025

$4.4m R&D Tax Incentive Received

November 16, 2025

2025 Annual General Meeting Chair Address & Presentation

November 16, 2025

FY25 Market Update

August 24, 2025

FY25 Results Release

August 24, 2025

FY25 Appendix 4E and Annual Report

August 24, 2025

Strategic Partnership with Tecan and Repado

July 21, 2025

1H FY25 Market Update

February 25, 2025

Positive Momentum For The First Half Result

February 25, 2025

Half Yearly Report and Accounts

February 25, 2025

$5m R&D Tax Incentive Received

November 21, 2024

2024 AGM Chairman's Address and CEO Presentation

November 19, 2024

Appendix 4E and Annual Report

August 30, 2024

Despatch Of Retail Entitlement Offer Booklet

June 12, 2024

Completion of Institutional Entitlement Offer and Placement

June 5, 2024

FDA Clearance and Capital Raising Presentation

June 4, 2024

Genetic Signatures Announces $30 Million Capital Raising

June 3, 2024

Genetic Signatures Appoints Allison Rossiter As CEO

June 3, 2024

FDA Clearance For Gastrointestinal Parasite Detection Kit

June 3, 2024

Trading Halt

May 31, 2024

Decision to Cease Development of US Respiratory Product

May 26, 2024

Leadership Transition at Genetic Signatures

April 29, 2024

TGA authorises supply of updated Respiratory Detection Kit

April 21, 2024

1H 24 Market Update

February 21, 2024

Genetic Signatures Rights Issue Offer Booklet

January 1, 2024

Genetic Signatures Successfully Completes Placement

December 28, 2023

Genetic Signatures Announces $15.9m Capital Raising

December 20, 2023

Capital Raising Presentation

December 20, 2023

Older news releases →

Calls

Decks

The 5 newest of 47 decks. Every deck is listed under its year.